CAS: 123606-06-4; 7-(Methylthio)-3-Nitro-[1,2,4]Triazolo[5,1-C][1,2,4]Triazin-4(6H)-One

该化合物是一个环环形化合物,其特征是复杂的三硝基和三氮环形结构,该化合物的特征是:甲基氟烷基化合物组,该化合物的含量增加,而硝基化合物组则增加其反应性和生物活动潜力;多氮原子在其结构中的存在表明,该化合物可能表现出与协调化学和药物或农用化学的潜在应用有关的有趣特性;该化合物独特的功能组群安排可影响其溶性,稳定性和再活动性,使其成为合成化学和药用研究的感兴趣对象;此外,该原子和功能组的具体安排可产生独特的电子特性,可以用于各种应用,包括作为潜在的药物候选物或材料科学.

结构式图片

相似化合物

76434-85-0 123606-07-5 372973-56-3

合成工艺路线路线简述

    📜Triazavirin,硫酸 反应生成沙匹替尼
    参考文献:Rusinov,V. L.;Ulomskij,E. N.;Chupaxin,O. N.;Zubairov,M. M.;Kapustin,+,Xim.-Farmats. Zh.,24,(1990) N,S. 41-44
    标题:Rusinov,V. L.;Ulomskij,E. N.;Chupaxin,O. N.;Zubairov,M. M.;Kapustin,+,Xim.-Farmats. Zh.,24,(1990) N,S. 41-44

    海关参考信息

    专利信息


    专利号:US-6177409-B1
    优先权日:1996-07-05
    标 题 :Method for the site specific synthesis of novel 3-hydroxypyridin-4(1H)ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications
    发明人:VANLEMMENS PIERRE PAUL; POSTEL DENIS GHISLAIN; GERMAIN PIERIG EMMANUEL; JULIEN RENE JEAN-MARIE; PETIT JEAN-PIERRE CONSTANT; RONCO GINO LINO; VILLA PIERRE JOSEPH
    权利人:INST BIOCHIMICO PAVESE PHARMA
    摘要:Process for regiospecific preparation of new 3-hydroxypyridine-4(1H)-one derivatives starting from monosaccharides or itols of general formula:in which R represents a radical, either saturated or not, branched or not, having carbon-atom groups, and having hetero-atoms or not, and Sub represents a saccharide derivative or an itol, either cyclic not, protected or not, the hydrocarbon skeleton of which is bound to the nitrogen atom of the pyridinone either directly or by the intermediary of a spacing group. The present invention is characterized in that the process comprises a first step of protection of the 3-hydroxy group of the pyranone derivative, a second basocatalyzed step of substitution of the intracyclic oxygen atom of the pyranone by the nitrogen atom of the amine function of the amino monosaccharide or amino itol, and a third step of de-protection of the 3-OH group of the pyridinone cycle and possibly of the OH groups of the glucide or itol residue. It also regards the products obtained by this process, as well as their applications, namely as medicaments for the treatment of toxic overloads of FeIII.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    This message contains search results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM). Do not reply directly to this message Sent On: Thu Oct 15
    14:14:09 2020 Search: Triazavirin 18 selected items Efficacy and safety of triazavirin therapy for coronavirus disease
    2019: A pilot randomized controlled trial. Engineering (Beijing). 2020 Sep 8. doi: 10.1016/j.eng.2020.08.011. Epub ahead of print.
    2: Wu X, Yu K, Wang Y, Xu W, Ma H, Hou Y, Li Y, Cai B, Zhu L, Zhang M, Hu X, Gao J, Wang Y, Qin H, Zhao M, Zhang Y, Li K, Du Z, Yang B. The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol. Engineering (Beijing). 2020 Jul 3. doi: 10.1016/j.eng.2020.06.011. Epub ahead of print.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知